Literature DB >> 22589585

Cloning and expression of malaria and tuberculosis epitopes in mycobacterium bovis bacille calmette-guérin.

Rapeah Suppian1, Zainul Fadziruddin Zainuddin, Mohd Nor Norazmi.   

Abstract

Mycobacterium bovis bacille Calmette-Guèrin (BCG) represents one of the most promising live vectors for the delivery of foreign antigens to the immune system. A recombinant BCG containing a synthetic gene coding for the malarial epitopes namely, the fragment 2 of region II of EBA-175 (F2R(II)EBA) and the repeat sequence of the circumsporozoite protein NANP generated in favour of mycobacterium codon usage using assembly PCR was constructed. Two T-cell epitopes of the 6-kDa M. tuberculosis early-secreted antigenic target (ESAT-6) antigen were also clone in the same construct. Expression of the synthetic gene was driven by the heat shock protein 65 (hsp65) promoter from M. tuberculosis and the signal peptide from the MPT63 antigen of M. tuberculosis. Expression of the composite epitopes was detected by Western blotting of the cell extract and culture supernatant of the recombinant clones using a specific rabbit polyclonal antibody against F2R(II)EBA. This study demonstrates the possibility of cloning and expressing immunogenic epitopes from causative agents of two important diseases: malaria and tuberculosis (TB) in a single recombinant BCG construct.

Entities:  

Keywords:  Assembly PCR; malaria; multivalent vaccine; recombinant BCG; tuberculosis

Year:  2006        PMID: 22589585      PMCID: PMC3347897     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  31 in total

1.  Malaria vaccine: are we anywhere close?

Authors:  D Raghunath
Journal:  J Postgrad Med       Date:  2004 Jan-Mar       Impact factor: 1.476

Review 2.  Pathways and strategies for developing a malaria blood-stage vaccine.

Authors:  M F Good; D C Kaslow; L H Miller
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis.

Authors:  L Brandt; T Oettinger; A Holm; A B Andersen; P Andersen
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

4.  Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.

Authors:  A Aldovini; R A Young
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein.

Authors:  H Liang; D L Narum; S R Fuhrmann; T Luu; B K Sim
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Gene replacement and expression of foreign DNA in mycobacteria.

Authors:  R N Husson; B E James; R A Young
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

7.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

8.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

9.  Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.

Authors:  B K Sim; P A Orlandi; J D Haynes; F W Klotz; J M Carter; D Camus; M E Zegans; J D Chulay
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

10.  Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.

Authors:  F Zavala; A H Cochrane; E H Nardin; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.